Skip to main content

CNH publishes 2026 Annual General Meeting agenda

CNH publishes 2026 Annual General Meeting agenda Basildon, March 25, 2026 CNH Industrial (NYSE: CNH) announced today that it has published its notice of the 2026 Annual General Meeting of Shareholders (“AGM”) and proxy statement. The AGM will be held on May 8, 2026, in Amsterdam, The Netherlands. The proceedings can also be followed via a live webcast on the Company’s website (www.cnh.com). The Company’s AGM materials and instructions for voting and submitting questions in advance of the meeting, together with those on how to follow the AGM remotely are available on the Company’s website at www.cnh.com, where they can be viewed and downloaded. Shareholders may request a hard copy of these materials, which include CNH Industrial’s audited financial statements, free of charge, through the contacts below. The Board of Directors has...

Continue reading

COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

TORONTO, ONTARIO, March 25, 2026 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”), a life science company focused on the development of natural, plant-based active ingredients, today reported its financial and operating results for the fourth quarter and full year ended December 31, 2025. All amounts in this press release are in U.S. dollars. Corporate Update Following the reconstitution of the Company’s board of directors (the “Board”) on May 30, 2025, the Company has undertaken a series of initiatives designed to follow through on the commitment of the reconstituted Board to actively review COSCIENS’ prospects and opportunities, and to take the actions necessary to best position COSCIENS to create value for shareholders. Notably, during the second half of 2025, the Company executed...

Continue reading

Enerpac Tool Group Reports Second Quarter Fiscal 2026 Results

Second Quarter of Fiscal 2026 Highlights*Net sales were $155 million, a 6% increase compared to the prior year, with a 2% increase in organic sales1. IT&S Product sales increased 6% organically, the highest growth in 10 quarters. Operating profit margin was 16.2% and adjusted operating profit margin was 19.0%. Net earnings were $16.3 million, or $0.31 per diluted share. Adjusted net earnings were $20.3 million, or $0.39 per diluted share. Adjusted EBITDA was $33.0 million and adjusted EBITDA margin was 21.3%. Year-to-date operating cash flow was $29 million, up from $16 million in the prior year. Returned approximately $51 million to shareholders through share repurchases. Won a five-year service contract with a major UK oil & gas customer. Launched six new products at ConExpo, including the recently acquired Hydra Pac diesel...

Continue reading

Integral Metals Appoints Leo Power to Board of Directors

CALGARY, Alberta, March 25, 2026 (GLOBE NEWSWIRE) — Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce the appointment of Leo Power to its Board of Directors, effective immediately. Mr. Power is an accomplished entrepreneur based in Newfoundland and Labrador, with extensive senior leadership experience across the energy and natural resource sectors. His background spans operations, investment, and corporate governance, providing a well-rounded perspective on advancing and scaling resource-focused companies. Mr. Power currently serves as Chief Executive Officer of Poseidon Energy Corp. and is a director of Q2 Metals Corp. He holds a joint MBA from the Kellogg School of Management and the Schulich School of Business, as well as a Master of Oil and Gas Studies from Memorial...

Continue reading

Montage Gold reports on its Q4-2025 activities

Koné project construction on-budget and ahead of schedule • Strong continued exploration focus • Robust liquidity sources CONSTRUCTION ACTIVITIESRapid progress achieved with +9.0 million hours worked to date, with more than 3,000 employees and contractors on-site Well on track for first gold pour in late Q4-2026 through the oxide circuit and on budget with $572.8 million of capital committed as at today, representing approximately 65% of the total upfront capital expenditure Key process plant achievements include completion of all CIL tanks and ball mill shell installation, oxide sizer completion, foundation concrete pours for pre-leach and tailings thickeners, and advancement of the hard-rock comminution circuit Other key infrastructure is well advanced including the full operation of the river abstraction and water storage facilities,...

Continue reading

Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress

Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using Dyadic’s production platform, with Dyadic eligible to receive a share of profits from product sales Expanded strategic collaboration with Fermbox Bio, including the launch of animal-origin-free recombinant DNase I (RNase-free) as the first commercialized product under the expanded partnership Signed an OEM distribution agreement with IBT Bioservices to commercialize Dyadic’s recombinant DNase I and transferrin for research and cell culture applications through IBT’s global distribution channels Entered a development and commercialization agreement with BRIG Bio to produce animal-free bovine alpha-lactalbumin for global nutrition markets, which includes funded development, milestones, and potential revenue participation Inzymes...

Continue reading

Pelican Acquisition Corporation (NASDAQ: PELI) Announces Completion of its Business Combination forming Greenland Energy Company

Greenland Energy to trade under new symbol on NASDAQ: GLND Jameson Land Basin includes over 2,000,000 acres covering the entire petroleum basin. Independent engineering report from Sproule ERCE indicates upside of 13 billion barrels of recoverable oil. Greenland Energy maintains the rights to own up to 70% of three onshore licenses of the Jameson Land Basin in East Greenland – the focus of extensive exploration and research for decades. The Business Combination creates a publicly traded energy company focused on enhancing global energy security through the responsible development of Greenland’s natural resources. $215 Million Implied Valuation for Greenland Energy. Think Equity continues to be financial advisor to GLND.HOUSTON, March 25, 2026 (GLOBE NEWSWIRE) — Pelican Acquisition Corporation (“Pelican”), a publicly traded...

Continue reading

Planet 13 Announces Q4 2025 Financial Results 

  ● Q4 2025 Revenue of $25.2 million  ● Q4 2025 Net loss of $4.6 million  ● Q4 2025 Adjusted EBITDA loss of $0.3 million     All results are reported in United States dollars ($) unless otherwise indicated. LAS VEGAS, March 25, 2026 (GLOBE NEWSWIRE) — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated cannabis company, today announced its financial results for the three-month and twelve-month periods ended December 31, 2025. Planet 13’s financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”). “Q4 began the turnaround we were looking for. Revenue stabilized across our footprint during a seasonally soft period, wholesale momentum returned in Nevada, and we exited the quarter with a cleaner, more focused...

Continue reading

Dime Declares Quarterly Cash Dividend for Common Stock

HAUPPAUGE, N.Y., March 25, 2026 (GLOBE NEWSWIRE) — Dime announced that its Board of Directors declared a quarterly cash dividend of $0.25 per share of Common Stock, payable on April 24, 2026 to common stockholders of record as of April 17, 2026. The Company continues its trend of uninterrupted dividends. ABOUT DIME Dime is a New York State-chartered trust company with approximately $15 billion in assets and the number one deposit market share on Greater Long Island (1). Investor Relations Contact:Avinash ReddySenior Executive Vice President – Chief Operating Officer and Chief Financial OfficerPhone: 718-782-6200; Ext. 5909Email: avinash.reddy@dime.com  ¹ Aggregate deposit market share for Kings, Queens, Nassau & Suffolk counties for community banks with less than $20 billion in assets. FORWARD-LOOKING STATEMENTSStatements contained...

Continue reading

Serina Therapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights

– FDA Grants IND Clearance for SER-252– SER-252 Phase 1b Trial Initiated– Closed Private Placement Financing of up to $30 Million HUNTSVILLE, March 25, 2026 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today reported its financial results for the full year ended December 31, 2025 and provided recent business highlights. “This past year was defined by execution, advancing SER-252 from IND filing through FDA clearance, into the clinic while strengthening our balance sheet to support the clinical milestones ahead,” said Steve Ledger, CEO of Serina. “With the first patient dosed in our registrational trial in advanced Parkinson’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.